Subject(s)
Coronavirus Infections/pathology , Erythema/virology , Foot Dermatoses/virology , Hand Dermatoses/virology , Pneumonia, Viral/pathology , Adolescent , Adult , Aged, 80 and over , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/virology , Female , Foot Dermatoses/pathology , Hand Dermatoses/pathology , Humans , Male , Pandemics , Pneumonia, Viral/epidemiology , Pneumonia, Viral/virology , SARS-CoV-2 , Toes/pathology , Young AdultSubject(s)
Alopecia Areata/therapy , Laser Therapy/methods , Adult , Female , Humans , Male , Middle AgedABSTRACT
Lichen sclerosus et atrophicus (LSA) is a chronic inflammatory disease of unknown cause that typically affects the genital area (1). It has been reported in post-traumatic areas as a result of Koebner phenomenon. LSA responds poorly to treatment making it a therapeutic challenge (2). Laser therapy has been described for LSA with variable results (3,4).
Subject(s)
Laser Therapy/instrumentation , Laser Therapy/methods , Lasers, Solid-State/therapeutic use , Lichen Sclerosus et Atrophicus/surgery , Aluminum , Cicatrix , Erbium , Female , Humans , Middle Aged , YttriumABSTRACT
Rosacea is a highly prevalent, chronic inflammatory disease. The use of topical ivermectin cream has recently been described in the treatment of rosacea in three clinical trials. We report our experience in a series of 34 patients treated with topical ivermectin cream. The results are a reflection of the reality of clinical practice and the perception of patients of the treatment. We also evaluate the efficacy in cases of mild rosacea and erythematotelangiectatic rosacea which have not been studied in trials.
Subject(s)
Antiparasitic Agents/therapeutic use , Ivermectin/therapeutic use , Rosacea/drug therapy , Administration, Cutaneous , Adolescent , Adult , Aged , Female , Humans , Male , Middle Aged , Skin Cream , Treatment Outcome , Young AdultABSTRACT
No disponible
